Events
Medical Crossfire®: ADCs and Bispecifics in Lung Cancer – Hype, Hope, or a New Standard
Room 103, Grand Ballroom, 1F
Presented by Physicians’ Education Resource. Supported by an educational grant from Merck & Co., Inc.
The Next Generation of Care: New Treatment Frontiers in Immunotherapy-Resistant Advanced Squamous NSCLC
Room 202, ASEM Ballroom, 2F
Presented by Global Learning Collaborative. Supported by an educational grant from BioNTech.
Exploring the Evolving Landscape of HER2-Mutant NSCLC: Placing the Patient at the Center of Care Throughout their Individual Treatment Journey
Room 103, Grand Ballroom, 1F
Presented by PeerVoice. Supported by an educational grant from Boehringer Ingelheim International Gmbh.
Building a Better Backbone for NSCLC and SCLC Treatment With PD-(L)1xVEGF-A Bispecific Antibodies: Inducing Immune Invigoration, Simplifying Treatment Delivery, and Enhancing Clinical Outcomes
Room 105, Grand Ballroom, 1F
Presented by Peerview. Supported by an educational grant from BMS/BioNTech.
The Lung Cancer Landscape: Covering Key Advances in NSCLC and SCLC
Room 104, Grand Ballroom, 1F
Presented by Medscape. Supported by educational grants from Gilead Sciences, Nuvalent, and Jazz Pharmaceuticals.
From Data to Decisions in HER2-Overexpressing NSCLC: Detecting Alterations, Implementing Therapeutic Advances, and Navigating Practicalities of Care
Room E5, Conference Room E, 3F
Presented by Peerview. Supported by an educational grant from Daiichi Sankyo, Inc.
Beyond PD-L1: Personalizing Immunotherapy in Genomic Subsets of Advanced NSCLC
Room 104, Grand Ballroom, 1F
Presented by Medscape. Supported by an educational grant from Regeneron.
